Steep declines in pediatric antidepressant use were documented following the 2004 release of new safety information associating antidepressants with a risk of suicidality. The authors examine whether declines in pediatric antidepressant use were steeper among individuals with certain clinical or family characteristics. The authors find that declines in antidepressant use were associated with new (as compared with ongoing) treatment episodes. Although rates of antidepressant use were higher among children of college-educated parents prior to risk disclosures, these children were more likely to forgo antidepressant medication than children of less educated parents after risk disclosures. The authors find that both children with and without psychiatric impairment experienced declines in antidepressant medication use following the risk warnings, although the decline occurred more quickly in the latter group. The authors’ findings highlight the need for additional data to assess the effects of risk disclosures on treatment patterns and health outcomes.
Aizer, A., & Stroud, L. (2010, March). Education, knowledge and the evolution of disparities in health (NBER Working Paper No. 15840). Cambridge, MA: National Bureau of Economic Research.
2.
Avorn, J., & Schneeweiss, S. (2009). Managing drug-risk information-What to do with all those new numbers. New England Journal of Medicine , 361, 647-649.
3.
Barry, C.L., & Busch, S.H. ( 2010). News media coverage of safety risks of pediatric antidepressants use. Pediatrics, 125, 88-95.
4.
Bird, H.R., Andrews, H., Schwab-Stone, M., Goodman, S., Dulcan, M., Richters, J., . . . Gould, M. ( 1996). Global measures of impairment for epidemiologic and clinical use with children and adolescents. International Journal of Methods in Psychiatric Research, 6, 295-307.
5.
Brent, D., Greenhill, L., Compton, S., Emslie, G., Wells, K., Walkup, J.T., . . . Turner, J.B. ( 2009). The treatment of adolescent suicide attempters (TASA): Predictors of suicidal events in an open treatment trial. Journal of the American Academy Child & Adolescent Psychiatry, 48, 987-996.
6.
Bridge, J.A., Greenhouse, J.B., & Weldon, A.H. ( 2008). Suicide trends among youths aged 10 to 19 years in the United States, 1996-2005. Journal of the American Medical Association, 300, 1025-1026.
7.
Busch, S.H., & Barry, C.L. ( 2009). Pediatric depression treatment in the aftermath of the black box warning. Health Affairs, 28, 724-733.
8.
Currie, J., & Stabile, M. ( 2009). Mental health in childhood and human capital. In J. Gruber (Ed.), The problems of disadvantaged youth: An economic perspective (NBER Working Paper No. 13217, pp. 115-148). Cambridge, MA: National Bureau of Economic Research.
9.
Ding, W., Lehrer, S.F., Rosenquist, N., & Audrain-McGovern, J. (2009). The impact of poor health on academic performance: New evidence using genetic markers. Journal of Health Economics, 28, 578-597.
10.
Fletcher, J.M. ( 2008). Adolescent depression: Diagnosis, treatment, and educational attainment. Health Economics, 17, 1215-1235.
11.
Gibbons, R.D., Brown, C.H., Hur, K., Marcus, S.M., Bhaumik, D.K., Erkens, J.A., . . . Mann, J.J. ( 2007). Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. American Journal of Psychiatry, 164, 1356-1363.
12.
Glied, S.A., & Lleras-Muney, A. (2003). Health inequality, education and medical innovation. Demography, 45, 741-761.
13.
Hammad, T.A., Laughren, T., & Racoosin, J. ( 2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63, 332-339.
14.
Harris, G. ( 2004, September 21). Study finds less youth antidepressant use . The New York Times. Retrieved from http://www.nytimes.com/2004/09/21/business/21drug.html
15.
Hartman, M., Martin, A., McDonnell, P., Catlin, A., and the National Health Expenditure Accounts Team. (2009). National health spending in 2007: Slower drug spending contributes to lowest rate of overall growth since 1998 . Health Affairs, 28, 246-261.
16.
Jick, H., Kaye, J.A., & Jick, S.S. ( 2004). Antidepressants and the risk of suicidal behaviors. Journal of the American Medical Association, 292, 338-343.
17.
Kleinman, L.C., & Norton, E.C. ( 2009). What’s the risk? A simple approach for estimating adjusted risk measures from nonlinear models including logistic regression . Health Services Research, 44, 288-302.
18.
Libby, A.M., Brent, E.H., Morrato, E.H., Orton, H.D., Allen, R., & Valuck, R.J. ( 2007). Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. American Journal of Psychiatry, 164, 884-891.
19.
Machlin, S., Yu, W., & Zodet, M. ( 2005). Computing standard errors for MEPS estimates. Rockville, MD: Agency for Healthcare Research and Quality .
20.
Nemeroff, C.B., Kalali, A., Keller, M.B., Charney, D.S., Lenderts, S.E., Cascade, E.F., . . . Schatzberg, A.F. (2007). Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States . Archives of General Psychiatry, 64, 466-472.
21.
Olfson, M., Marcus, S.C., & Druss, B.G. ( 2008). Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Archives of General Psychiatry, 65, 94-101.
22.
Rosack, J. ( 2005). New data show declines in antidepressant prescribing . Psychiatric News, 40(17), 1-39.
23.
Rosenzweig, M.R., & Schultz, T.P. ( 1989). Schooling, information and nonmarket productivity: Contraceptive use and its effectiveness. International Economic Review, 30, 457-477.
24.
U.S. Department of Health and Human Services. ( 1999). Mental health: A report of the Surgeon General. Rockville, MD: U.S. DHHS, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health.
